ViroGates AS (FRA:EP2) Total Premiums Earned

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:EP2 ViroGates AS FRA:EP2
24 GF Score
Price €1.45
GF Value €0.87
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is ViroGates AS Total Premiums Earned?

Total Premiums Earned only applies to insurance companies.

FRA:EP2
24GF Score
ViroGates AS FRA:EP2
Total Premiums Earned is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ViroGates AS (FRA:EP2) Overvalued in 2026?

Based on GuruFocus' analysis, ViroGates AS stock appears to be overvalued. The current stock price of €1.45 is trading 66.7% above its estimated GF Value™ of €0.87. GuruFocus considers ViroGates AS to be Significantly Overvalued.

Key valuation signals for FRA:EP2:

  • Total Premiums Earned:
  • GF Value™: €0.87 vs. price of €1.45 (66.7% above fair value)
  • GF Score™: 24/100 with 2 warning signs

No single metric tells the full story. See the FRA:EP2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ViroGates AS Business Description

Other Exchanges VIRO:Denmark
Address Banevaenget 13, Birkerod, DNK, 3460
ViroGates AS is an international medical technology company that develops and markets blood tests to measure chronic inflammation at health clinics and hospitals. The company markets its blood test products under the suPARnostic brand. Its product portfolio comprises suPARnostic TurbiLatex, suPARnostic Quick Triage, and suPARnostic Auto Flex ELISA kit. These products are mainly used to measure the suPAR (soluble urokinase Plasminogen Activator Receptor) protein in the bloodstream.
24GF Score

Get the complete analysis for FRA:EP2

Total Premiums Earned is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.45
Price
€0.87
GF Value